4 claims that cleared review. Each one shows what has to be true for it to hold and how strongly it is supported — including the places the sources contradict each other.
A very-low-calorie ketogenic diet (VLCKD), as used in medically supervised clinical protocols, combines severe caloric restriction (roughly 600-800 kcal/day) with a low carbohydrate intake (roughly 20-60 g/day, up to 30-50 g or 13-25% of energy) -- distinct from a generic very-low-calorie diet (400-800 kcal/day), which is only ketogenic if carbohydrate is also substantially restricted.
A very-low-calorie ketogenic diet is a strict, doctor-supervised plan of about 600-800 calories and very little carbohydrate a day. It's different from a generic very-low-calorie diet, which isn't automatically ketogenic.
Safety. Needs medical supervision — do not act on this without a clinician.
Only when
VLCKD trial protocol also specified 1.2-1.5 g protein/kg ideal body weight from high-biological-value sources, and 15-30 g fat mainly from extra virgin olive oil and omega-3 PUFAs (rondanelli-mariangela)
these are medically supervised protocols, not self-directed dieting
a very-low-calorie diet (VLCD) that does not also restrict carbohydrate substantially is not ketogenic (watanabe-m)
Who
overweight or obese adults undertaking a medically supervised VLCKD · Not general population attempting self-directed severe calorie/carbohydrate restriction without clinical supervision
Moderate confidence
Three independent persons, strongest evidence is a meta-analysis (rondanelli-mariangela), but that source's claim carries a disclosed conflict of interest: a co-author on that paper (sajoux-ignacio) is a Scientific Officer at PronoKal Group, a commercial VLCKD program. The remaining two sources are lower-tier (unclear, author_assertion). Named per editorial policy rule 3c; still counted as support but discounted in confidence.
3 independent people · 3 sources · strongest evidence: meta analysis
Sources
Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials. · BMC medicine · 2023 · doi:10.1186/s12916-023-02874-y
Does the Ketogenic Diet Mediate Inflammation Markers in Obese and Overweight Adults? A Systematic Review and Meta-Analysis of Randomized Clinical Trials. · Nutrients · 2024 · doi:10.3390/nu16234002
Scientific evidence underlying contraindications to the ketogenic diet: An update. · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2020 · doi:10.1111/obr.13053
Major diabetes-care guidelines, including the American Diabetes Association's Standards of Care, recognize low-carbohydrate and very-low-carbohydrate diets as an appropriate option for adults with diabetes or prediabetes, improving glycemic control (including HbA1c) and potentially allowing reduced glucose-lowering medication. Anyone taking glucose-lowering or blood-pressure medication should make this change only with their clinician, since doses may need adjusting.
Diabetes guidelines say a low-carb diet is a reasonable option for many people with diabetes or prediabetes -- it can improve blood sugar and sometimes let you reduce medication, but only with your doctor's involvement.
Safety. Needs medical supervision — do not act on this without a clinician.
Only when
applies to low-carbohydrate diets generally, not specifically the ketogenic diet (malinowska-d's paper is explicit on this point)
medication dose reduction is a potential outcome requiring clinician oversight, not a guaranteed or self-directed result
"selected individuals" -- not a blanket recommendation for everyone with diabetes
Who
adults with type 2 diabetes or prediabetes, selected per clinician judgment
Moderate confidence
Three independent papers converge on the same underlying ADA guideline position, but none is primary trial evidence -- this principle reports guideline consensus, not independently replicated trial data. 'guideline' (dynka-d) is not on the formal evidence ladder (meta_analysis>rct>observational>mechanistic>clinical_experience>author_assertion); treated cautiously as at or above clinical_experience tier, which caps overall confidence at moderate.
3 independent people · 3 sources · strongest evidence: guideline
Sources
Ketogenic Diet in Obesity and Diabetes: A Narrative Review. · Nutrients · 2026 · doi:10.3390/nu18122004
Ketogenic Diet: A Review of Composition Diversity, Mechanism of Action and Clinical Application. · Journal of nutrition and metabolism · 2024 · doi:10.1155/2024/6666171
Ketogenic dietary therapy is delivered in several distinct forms -- including the classic ketogenic diet, the modified Atkins diet, a medium-chain-triglyceride ketogenic diet, and a low-glycemic-index approach -- which differ mainly in their fat-to-carbohydrate ratio and dietary flexibility.
There isn't just one 'keto diet' -- there are several versions that differ in how strict the fat-to-carb ratio is and how much flexibility they allow, from the classic strict version to more flexible variants.
Only when
classic ketogenic diet: fat-to-carbohydrate ratio of roughly 3:1 to 4:1
modified Atkins diet: fat-to-carbohydrate ratio of roughly 1:1 to 2:1, more flexible than the classic form
medium-chain-triglyceride (MCT) ketogenic diet: more flexible and higher carbohydrate tolerance than the classic diet, because MCTs yield more ketones per kilocalorie than long-chain triglycerides
low-glycemic-index treatment: related but not a true ketogenic diet -- it limits total daily carbohydrate and favors low-glycemic-index foods rather than targeting a specific fat-to-carbohydrate ratio
Who
general adults; the specific fat-to-carbohydrate ratios are documented in the pediatric/infant epilepsy literature but the taxonomy itself is described generally
Moderate confidence
Two independent review-type sources (chen-s, an umbrella review; newmaster-k, a narrative review) agree on the same four-way taxonomy, though chen-s's evidence_type is marked 'unclear' and newmaster-k's population is pediatric epilepsy rather than the general/metabolic-health population this library targets. Evidence type is not RCT/meta-analysis for this descriptive claim, so confidence is moderate rather than high.
Ketogenic Diet and Multiple Health Outcomes: An Umbrella Review of Meta-Analysis. · Nutrients · 2023 · doi:10.3390/nu15194161
Long-term adherence to a ketogenic diet is difficult to sustain because of its restrictiveness (dietary monotony, psychosocial burden, and meal-preparation demands), and this is especially pronounced in populations with culturally high habitual fruit and vegetable intake, such as Mediterranean populations, where long-term compliance and effectiveness have been observed to be low.
Keto diets are hard to stick with long-term because they're restrictive and repetitive, especially if fruits and vegetables are a big part of your normal eating. Plan for that difficulty up front rather than assuming willpower will carry you.
Only when
Applies to adults with obesity or type 2 diabetes following a ketogenic diet (KD).
Adherence barriers include dietary monotony, psychosocial burden, meal-preparation demands, and the need to avoid fruit and some fresh vegetables.
Effect is most pronounced in populations/cultures where fruit and vegetable consumption is habitual and culturally valued (e.g. Mediterranean-area populations); one such population showed low long-term compliance and effectiveness.
Who
Adults with obesity or type 2 diabetes considering or following a ketogenic diet, particularly in dietary cultures with high habitual fruit/vegetable intake
Moderate confidence
Two independent authors of review articles (a narrative review and a systematic review) agree; both describe adherence challenges qualitatively rather than with a strong causal effect size, and one source's evidence_type is "unclear", so this stays at moderate rather than high.
2 independent people · 2 sources · strongest evidence: observational
Sources
Ketogenic Diet in Obesity and Diabetes: A Narrative Review. · Nutrients · 2026 · doi:10.3390/nu18122004
Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review. · Current diabetes reports · 2021 · doi:10.1007/s11892-021-01399-z
This is a summary of published research, not medical advice. It cannot account for your medications, conditions or history. Talk to a clinician before acting on any of it.